The benefit of elobixibat in chronic constipation is associated with faecal deoxycholic acid but not effects of altered microbiota
Authors:
Open Access
- 20 July 2020
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 52 (5) , 821-828
Abstract
Summary: Background: Elobixibat, a novel inhibitor of apical sodium‐dependent bile acid transporter for treating chronic constipation, increases colonic bile acid concentrations, stimulating bowel function. However, it is not clear which bile acids are altered, or whether altered gut microbiota are associated with functional effects that may alter bowel function.Aims: To investigate the effects of elobixibat on changes in the faecal concentrations of total and individual bile acids and in faecal microbiota.Methods: This was a prospective, single‐centre study. After baseline period, patients received 10 mg daily of elobixibat for 2 weeks. We evaluated the effects on bowel function, changes in faecal bile acid concentrations and composition of gut bacteria, before and after elobixibat administration.Results: In the 30 patients analysed, the frequency of pre‐ and post‐treatment bowel movements per fortnight was 7 and 10 (P < 0.001), respectively. The pre‐treatment faecal bile acid concentration increased significantly from 10.9 to 15.0 µg/g stool post‐treatment (P = 0.030), with a significant increase in faecal deoxycholic acid (pre‐treatment 3.94 µg/g stool to post‐treatment 5.02 µg/g stool, P = 0.036) and in glycine‐conjugated deoxycholic and chenodeoxycholic acids. Shannon index was significantly decreased, but there were no significant changes at the genus and phylum levels.Conclusions: Short term treatment with elobixibat increased the concentrations of total bile acids and deoxycholic acid and decreased the diversity of faecal microbiota. The biological effects of elobixibat are associated with its effects on secretory bile acids, rather than the structural changes of an altered faecal microbiota.Keywords
This publication has 28 references indexed in Scilit:
- Predictive functional profiling of microbial communities using 16S rRNA marker gene sequencesNature Biotechnology, 2013
- The Receptor TGR5 Mediates the Prokinetic Actions of Intestinal Bile Acids and Is Required for Normal Defecation in MiceGastroenterology, 2013
- Bile acids: regulation of synthesisJournal of Lipid Research, 2009
- Chronic constipation: a survey of the patient perspectiveAlimentary Pharmacology & Therapeutics, 2007
- Bile salt biotransformations by human intestinal bacteriaJournal of Lipid Research, 2006
- Use of 16S rRNA Gene-Targeted Group-Specific Primers for Real-Time PCR Analysis of Predominant Bacteria in Human FecesApplied and Environmental Microbiology, 2004
- A G Protein-coupled Receptor Responsive to Bile AcidsJournal of Biological Chemistry, 2003
- How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form.Gut, 1991
- Dose-related effects of chenodeoxycholic acid in the rabbit colonDigestive Diseases and Sciences, 1980
- Colonic Secretion of Water and Electrolytes Induced by Bile Acids: Perfusion Studies in ManJournal of Clinical Investigation, 1971